Quotes 5-day view End-of-day quote Nasdaq
Antares Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. The Company develops, manufactures, and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. The Company products include XYOSTED...
Ratings of Antares Pharma, Inc.
All news about ANTARES PHARMA, INC.
05/24 ANTARES PHARMA, INC. : Entry into a Material Definitive Agreement, Termination of a Materi..
05/24 Antares Pharma, Inc. Announces Management Changes
05/24 ANTARES PHARMA, INC.(NASDAQCM : ATRS) dropped from NASDAQ Composite Index
05/24 ANTARES PHARMA, INC.(NASDAQCM : ATRS) dropped from S&P Pharmaceuticals Select Industry Ind..
05/24 ANTARES PHARMA, INC.(NASDAQCM : ATRS) dropped from S&P Global BMI Index
05/24 ANTARES PHARMA, INC.(NASDAQCM : ATRS) dropped from S&P TMI Index
05/12 Halozyme Says Antitrust Act Waiting Period Expires for Antares Pharma Acquisition
05/10 ANTARES PHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
05/10 Antares Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 202..
05/05 ANTARES PHARMA INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
04/26 Halozyme Therapeutics Launches Cash Tender Offer to Acquire Antares Pharma Shares
04/25 ANTARES PHARMA INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
04/14 Ladenburg Thalmann Downgrades Antares Pharma to Neutral From Buy
04/14 HC Wainwright Downgrades Antares Pharma to Neutral From Buy; Price Target is $5.60
04/14 Piper Sandler Downgrades Antares Pharma to Neutral From Overweight, Adjusts Price Targe..
News in other languages on ANTARES PHARMA, INC.
Analyst Recommendations on ANTARES PHARMA, INC.
Chart ANTARES PHARMA, INC.